Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
Tarazona N, Gimeno-Valiente F, Gambardella V, Zuñiga S, Rentero-Garrido P, Huerta M, Roselló S, Martinez-Ciarpaglini C, Carbonell-Asins JA, Carrasco F, Ferrer-Martínez A, Bruixola G, Fleitas T, Martín J, Tébar-Martínez R, Moro D, Castillo J, Espí A, Roda D, Cervantes A. Tarazona N, et al. Among authors: carrasco f. Ann Oncol. 2019 Nov 1;30(11):1804-1812. doi: 10.1093/annonc/mdz390. Ann Oncol. 2019. PMID: 31562764 Free article.
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression.
Martinez-Ciarpaglini C, Oltra S, Roselló S, Roda D, Mongort C, Carrasco F, Gonzalez J, Santonja F, Tarazona N, Huerta M, Espí A, Ribas G, Ferrández A, Navarro S, Cervantes A. Martinez-Ciarpaglini C, et al. Among authors: carrasco f. Mod Pathol. 2019 Feb;32(2):306-313. doi: 10.1038/s41379-018-0124-5. Epub 2018 Sep 11. Mod Pathol. 2019. PMID: 30206410 Free article.
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy.
Fleitas-Kanonnikoff T, Martinez-Ciarpaglini C, Ayala J, Gauna C, Denis R, Yoffe I, Sforza S, Martínez MT, Pomata A, Ibarrola-Villava M, Arevshatyan S, Burriel V, Boscá D, Pastor O, Ferrer-Martinez A, Carrasco F, Mongort C, Navarro S, Ribas G, Cervantes A. Fleitas-Kanonnikoff T, et al. Among authors: carrasco f. Cancer Med. 2019 Jun;8(6):3120-3130. doi: 10.1002/cam4.2191. Epub 2019 May 6. Cancer Med. 2019. PMID: 31059199 Free PMC article.
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, Torres AA, Morales S, Ortega PT, Gil VLO, Sampedro T, Conejero RA, Calvo-Martinez L, Galve-Calvo E, López R, de la Pena FA, Lopez-Tarruella S, de Araguiz BAHF, Ruiz LB, Cardenas TM, Chacon JI, Antón FM. Martínez-Jañez N, et al. Among authors: carrasco fh. Breast Cancer Res Treat. 2024 Apr 1. doi: 10.1007/s10549-024-07287-w. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38561577
[Commitment of Asunción. A call to action].
Ferreira Heyn AM, Kliger G, Jiménez MC, Bareiro Arce A, Franco Núñez R, Adrianza Baptista G, Cárdenas D, Carrasco F, Castillo Pineda JC, Correia MIT, Jáquez A, Figueredo-Grijalba R. Ferreira Heyn AM, et al. Among authors: carrasco f. Nutr Hosp. 2024 Feb 15;41(1):249-254. doi: 10.20960/nh.05100. Nutr Hosp. 2024. PMID: 38224307 Free article. Spanish.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Balmaña J, Fasching PA, Couch FJ, Delaloge S, Labidi-Galy I, O'Shaughnessy J, Park YH, Eisen AF, You B, Bourgeois H, Gonçalves A, Kemp Z, Swampillai A, Jankowski T, Sohn JH, Poddubskaya E, Mukhametshina G, Aksoy S, Timcheva CV, Park-Simon TW, Antón-Torres A, John E, Baria K, Gibson I, Gelmon KA; LUCY investigators. Balmaña J, et al. Breast Cancer Res Treat. 2024 Apr;204(2):237-248. doi: 10.1007/s10549-023-07165-x. Epub 2023 Dec 19. Breast Cancer Res Treat. 2024. PMID: 38112922 Free PMC article. Clinical Trial.
Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management.
Arteagoitia Bolumburu A, Monteagudo Ruiz JM, Mahia P, Pérez David E, González T, Sitges M, Li CH, Alonso D, Carrasco F, Luna Morales M, Adeba A, de la Hera JM, Zamorano JL. Arteagoitia Bolumburu A, et al. Among authors: carrasco f. JACC Cardiovasc Imaging. 2024 Jun;17(6):579-591. doi: 10.1016/j.jcmg.2023.10.006. Epub 2023 Dec 6. JACC Cardiovasc Imaging. 2024. PMID: 38069980
[Intermittent fasting and human metabolic health].
Carvajal V, Marín A, Gihardo D, Maluenda F, Carrasco F, Chamorro R. Carvajal V, et al. Among authors: carrasco f. Rev Med Chil. 2023 Feb;151(1):81-100. doi: 10.4067/s0034-98872023000100081. Rev Med Chil. 2023. PMID: 37906749 Free article. Review. Spanish.
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: carrasco fp. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
168 results